Physician

Munveer Bhangoo, MD

According to 2025 Medicare claims, Munveer Bhangoo, MD (NPI: 1235499518) practices hematology/oncology in the San Diego-Chula Vista-Carlsbad, CA market, with the plurality of this provider's patient population coming from San Diego, CA. This provider's primary affiliated billing organization is SCRIPPS HEALTH (NPI: 1275899072; TIN: 232380812) and primary practice location at 92054-5661. Bhangoo is affiliated with the Scripps Accountable Care Organization, LLC (ACO ID: A3521), participating under the MSSP model.

Bhangoo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,037 traditional Medicare patients, billed 258,359 HCPCS/CPT codes, and received $5,859,002 in Medicare payments. The top billing code was J9217 (Leuprolide acetate (for depot suspension), 7.5 mg). Part D data shows 2,780 prescription claims across 359 beneficiaries totaling $5,521,561 in drug costs, led by Tagrisso (Osimertinib Mesylate). 2020 DME data shows 14 claims. Open Payments data shows 172 records totaling $93,706. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $74,085 to $5,859,002. Similarly, Part D prescription costs have moved sharply higher in recent years, from $11,287 to $5,521,561. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	172	684	$74,085
2016	173	836	$87,537
2017	122	1,155	$43,432
2018	238	25,179	$589,138
2019	526	118,692	$1,815,433
2020	517	124,266	$2,777,758
2021	595	124,313	$3,124,825
2022	612	141,016	$3,392,855
2023	719	167,347	$4,018,106
2024	1,037	258,359	$5,859,002

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	35	168	$11,287
2016	63	466	$56,871
2017	59	623	$45,349
2018	71	358	$534,688
2019	227	978	$2,722,419
2020	230	1,481	$3,766,224
2021	222	1,660	$4,008,485
2022	289	2,085	$5,284,194
2023	306	2,484	$5,560,324
2024	359	2,780	$5,521,561

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	14	$1,513
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	159	986	$140
96413	Administration of chemotherapy into vein, 1 hour or less	204	726	$117
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	531	1,531	$104
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	212	290	$72
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	197	355	$55

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tagrisso	Osimertinib Mesylate	63	1,890	$1,057,106
Cabometyx	Cabozantinib S-Malate	41	1,230	$1,002,687
Xtandi	Enzalutamide	76	2,400	$972,910
Abiraterone Acetate	Abiraterone Acetate	868	26,798	$649,606
Nubeqa	Darolutamide	29	870	$387,231

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	170	$82,560	Exelixis Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$11,146	Merck Sharp & Dohme LLC
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Munveer Bhangoo, MD?

Tedicare shows public-source Medicare data for Munveer Bhangoo, MD (NPI 1235499518), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Munveer Bhangoo, MD have ACO affiliation data?

Munveer Bhangoo, MD is shown with ACO affiliation data for Scripps Accountable Care Organization, LLC (MSSP, ACO ID A3521).

What billing organization is linked to Munveer Bhangoo, MD?

Munveer Bhangoo, MD is linked to SCRIPPS HEALTH (billing NPI 1275899072) in the available physician profile data.

Does Munveer Bhangoo, MD have Open Payments data?

Munveer Bhangoo, MD has 172 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.